Fundz

Intellistem reported raising $1.2 Million in an initial SEC Form D filing, from an offering of $1.5 Million

PRIVATEApr 18, 2024Late filing, first sale May 26, 2022$1.2M of $1.5M raised

Amount Raised

$1.2 Million

$1.2 Million sold, per SEC Form D (first sale May 26, 2022)

Round Type

Seed

San FranciscoHealthcare

Quick answer

Intellistem raised $1.2 Million in a Seed round, dated May 26, 2022. Intellistem is based in San Francisco, California, United States.

How much did Intellistem raise?
Intellistem raised $1.2 Million in a Seed round on May 26, 2022.
What does Intellistem do?
Intellistem, Inc. is a clinical-stage biotech that develops innovative cellular immune cancer therapy approaches.
Where is Intellistem based and how big is it?
Intellistem is based in San Francisco, California, United States.
Who are the decision-makers at Intellistem?
Fundz holds 1 contact at Intellistem. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Intellistem that raised within 45 days of this round, from Fundz verified event records.

  • PharmaCann Penn raised $25M on July 8, 2022.
  • Lorelei Integrated Therapeutics, Inc. raised $1M (Seed) on July 8, 2022.
  • Good Clean Love, Inc. raised $18M on July 8, 2022.
  • Imagen Dental Partners raised $457K on July 8, 2022.
  • Cleanse raised $500K (Seed) on July 8, 2022.
  • Sibel Health raised $25M on July 8, 2022.

Who to call at Intellistem, and when

A new round usually means Intellistem is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Intellistem raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Intellistem, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Intellistem. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Intellistem

Location

440 DAVIS COURT #901

San Francisco, California, United States

About

Intellistem, Inc. is a clinical-stage biotech that develops innovative cellular immune cancer therapy approaches. The Company has demonstrated the therapeutic potential and safety of its' Super Sentinel Gamma Delta Cell (SCC) Platform in Human Studies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Intellistem raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Intellistem's next move

See what Strategic adds

Intellistem raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.